Federal contractor · public award history
HEALTH DECISIONS, INC.
Parent: HEALTH DECISIONS, INC. CMKQYLSLNJG1
- Awards we know about
- 13
- Typical size
- $2.10M
- Middle of their public awards
- Dollars on those awards
- $39.29M
Most of their awards we can see fall roughly between $1.15M and $4.31M.
SAM.gov registration
Public extract 2026-07-05
- Status
- Active
- Purpose of registration
- All awards (Z2)
- Registration expires
- Feb 16, 2027
- Activation date
- Feb 18, 2026
- Primary NAICS (SAM)
- 541714
Business types (SAM)
Registration fields from the official SAM.gov public entity extract (monthly bulk). Not a substitute for live SAM checks.
From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.
Awarding agencies
- Department of Health and Human Services (13)
Industries & product codes
Award history
- Department of Health and Human Services$3.17M
IGF::OT::IGF EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS OF CONTRACEPTIVE EFFICACY AND SAFETY OF MULTIPURPOSE PREVENTION TECHNOLOGIES PRODUCTS
- Department of Health and Human Services$3.59M
TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020.
- Department of Health and Human Services$233,291
NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE
- Department of Health and Human Services$1.20M
ACQUISITION OF THE NESTORONE ESTRADIOL (NES/E2) VAGINAL RING
- Department of Health and Human Services$2.03M
STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION"
- Department of Health and Human Services$1.59M
TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION
- Department of Health and Human Services$700,175
NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE
- Department of Health and Human Services$6.45M
COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
- Department of Health and Human Services$2.16M
FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL
- Department of Health and Human Services—
TO CREATE AN INDEFINITE DELIVERY/INDEFINITE QUANTITY CONTRACT FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2026
- Department of Health and Human Services$7.37M
IGF::OT::IGF CONTRACEPTIVE CLINICAL TRIALS NETWORK TO6 - COORDINATION OF CLINICAL TRIALS OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION -
- Department of Health and Human Services$9.78M
HHSN275201200002I/HHSN27500009 - CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTIVENESS, ACCEPTABILITY, AND SAFETY - HEALTH DECISIONS, INC - CAN 8030701
- Department of Health and Human Services$994,099
PROTOCOL FINALIZATION, START-UP, COORDINATION, MONITORING, AND ALL OTHER ASSOCIATED ACTIVITIES FOR CLINICAL TRIALS EVALUATING PROGESTOGENIC ANDROGENS AS CONTRACEPTIVE AGENTS
Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.